Status:
UNKNOWN
Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Influenza
Acquired Immune Deficiency Syndrome
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Influenza vaccination has proved it's effectiveness over many years of usage including HIV/AIDS patients who are immunocompromised. In those patients, however, a noted rise in HIV viral load which fol...
Detailed Description
We will test the effectiveness of mesotherapy as a vehicle for influenza vaccination.We will use 1:10th of the amount of seasonal trivalent influenza vaccine in approx.50 HIV/AIDS patients.A control g...
Eligibility Criteria
Inclusion
- Virologic diagnosis of HIV/AIDS.
- Any immune derangement is acceptable
Exclusion
- Allergy to eggs
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00758212
Start Date
November 1 2008
End Date
April 1 2009
Last Update
October 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah U. hospital
Jerusalem, Israel